Mean intensity curve on dynamic contrast-enhanced susceptibility-weighted perfusion MR imaging - review of a new parameter to differentiate intracranial tumors

Journal of Neuroradiology

Volumn 38, Issue 4, 2011, Pages 199-206

  Chinchure, S ^a   Thomas, B ^a   Wangju, S ^a   Jolappara, M ^a   Kesavadas, C ^a   Kapilamoorthy, T R ^a   Radhakrishnan, V V ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Brain tumors; DSC; Mean perfusion curve; MRI; Perfusion

Indexed keywords

BRAIN BLOOD FLOW; BRAIN SCINTISCANNING; CANCER GRADING; CAPILLARY DENSITY; CARCINOGENESIS; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; GLIOMA; HEMANGIOBLASTOMA; HUMAN; INTRACRANIAL TUMOR; LYMPHOMA; MENINGIOMA; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOCYTIC ASTROCYTOMA; REVIEW; STEREOTACTIC BIOPSY; SUSCEPTIBILITY WEIGHTED IMAGING;

BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING;

EID: 80053560062     PISSN: 01509861     EISSN: 17730406     Source Type: Journal    
DOI: 10.1016/j.neurad.2011.07.002     Document Type: Review

References (46)

1. Knopp E.A., Cha S., Johnson G., Mazumdar A., Golfinos J.G., Zagzag D., et al. Glial neoplasms: dynamic contrast-enhanced T2$-weighted MR imaging. Radiology 1999, 211:791-798.
2. Sugahara T., Korogi Y., Shigematsu Y., Hirai T., Ikushima I., Liang L., et al. Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J Comput Assist Tomogr 1999, 23:232-237.
3. Aronen H.J., Perkio J. Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin N Am 2002, 12:501-523.
4. Cha S., Knopp E.A., Johnson G., Wetzel S.G., Litt A.W., Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002, 223:11-29.
5. Rosen B.R., Belliveau J.W., Vevea J.M., Brady T.J. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990, 14:249-265.
6. Belliveau J.W., Rosen B.R., Kantor H.L., et al. Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 1990, 14:538-546.
7. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971, 285:1182-1186.
8. Jackson A., Kassner A., Annesley-Williams D., Reid H., Zhu X.P., Li K.L. Abnormalities in recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. Am J Neuroradiol 2002, 23:7-14.
9. Provenzale J.M., Wang G.R., Brenner T., Petrella J.R., Sorensen A.G. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. Am J Roentgenol 2002, 178:711-716.
10. Abdulrauf S.I., Edvardsen K., Ho K.L., Yang X.Y., Rock J.P., Rosenblum M.L. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998, 88:513-520.
11. Lev M.H., Rosen B.R. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 1999, 9:309-331.
12. Poussaint T.Y., Rodriguez D. Advanced neuroimaging of pediatric brain tumors: MR diffusion, MR perfusion, and MR spectroscopy. Neuroimag Clin N Am 2006, 16:169-192.
13. Roberts H.C., Roberts T.P., Brasch R.C., Dillon W.P. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. Am J Neuroradiol 2000, 21:891-899.
14. Aronen H.J., Gazit I.E., Louis D.N., Buchbinder B.R., Pardo F.S., Weisskoff R.M., et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994, 191:41-51.
15. Sugahara T., Korogi Y., Kochi M., Ikushima I., Hirai T., Okuda T., et al. Correlation of MR imaging determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Am J Roentgenol 1998, 171:1479-1486.
16. Law M., Yang S., Wang H., Babb J.S., Johnson G., Cha S., et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 2003, 24:1989-1998.
17. Arvinda H.R., Kesavadas c, Sarma P.S., Thomas B., Radhakrishnan V.V., Gupta A.K., et al. Glioma grading: sensitivity, specificity, positive and negative predictive values of values of diffusion and perfusion imaging. J Neuro Oncol 2009, 94:87-96.
18. Henry R.G., Vigneron D.B., Fischbein N.J., Grant P.E., Day M.R., Noworolski S.M., et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. Am J Neuroradiol 2000, 21:357-366.
19. Poussaint T.Y., Rodriguez D. Advanced neuroimaging of pediatric brain tumors: MR diffusion, MR perfusion, and MR spectroscopy. Neuroimaging Clin N Am 2006, 16:169-192.
20. Wong J.C., Provenzale J.M., Petrella J.R. Perfusion MR imaging of brain neoplasms. Am J Roentgenol 2000, 174:1147-1157.
21. Danchaivijitr N., Waldman A.D., Tozer D.J., Benton C.E., Brasil Caseiras G., Tofts P.S., et al. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?. Radiology 2008, 247:170-178.
22. Law M., Oh S., Babb J.S., Wang E., Inglese M., Zagzag D., et al. Low-grade gliomas: dynamic susceptibility-weighted contrast enhanced perfusion MR imaging - prediction of patient clinical response. Radiology 2006, 238:658-667.
23. Provenzale, Mukundan S., Barboriak D.P., Diffusion-weighted, Perfusion MR Imaging for brain tumor characterization and assessment of treatment response. Radiology 2006, 239:632-649.
24. Sugahara T., Korogi Y., Tomiguchi S., Shigematsu Y., Ikushima I., Kira T., et al. Post-therapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast- enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. Am J Neuroradiol 2000, 21:901-909.
25. Barajas R.F., Chang J.S., Segal M.R., Parsa A.T., McDermott M.W., et al. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2009, 253:486-496.
26. Dandois V., Rommel D., Renard L., Jamart J., Cosnard G. Substitution of 11C-methionine PET by perfusion MRI during the follow-up of treated high-grade gliomas: preliminary results in clinical practice. J Neuroradiol 2010, 37(2):89-97.
27. Hlaihel C., Guilloton L., Guyotat J., Streichenberger N., Honnorat J., Cotton F. Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas. J Neurooncol 2010, 97:73-80.
28. Soonmee Cha, Sean Pierce, Knopp E.A., Johnson G., Yang C., Ton A., et al. Dynamic contrast-enhanced T2$-weighted MR imaging of tumefactive demyelinating lesions. Am J Neuroradiol 2001, 22:1109-1116.
29. Holveck A., Grand S., Boini S., Kirchin M., Le Bas J.F., Dietemann J.L., et al. Dynamic susceptibility contrast-enhanced MRI evaluation of cerebral intraventricular tumors: preliminary results. J Neuroradiol 2010, 37(5):269-275.
30. Desclée P., Rommel D., Hernalsteen D., Godfraind C., de Coene B., Cosnard G. Gliomatosis cerebri, imaging findings of 12 cases. J Neuroradiol 2010, 37(3):148-158.
31. Chatterjee S., Saini J., Kesavadas C., Arvinda H.R., Jolappara M., Gupta A.K. Differentiation of tubercular infection and metastasis presenting as ring enhancing lesion by diffusion and perfusion magnetic resonance imaging. J Neuroradiol 2010, 37(3):167-171.
32. Lehmann P., Vallée J.N., Saliou G., Monet P., Bruniau A., Fichten A., et al. Dynamic contrast-enhanced T2$-weighted MR imaging: a peritumoral brain oedema study. J Neuroradiol 2009, 36(2):88-92.
33. Thomas B. MR perfusion imaging and intensity - time curve analysis in cerebral tumors. Proc Intl Soc Mag Reson Med 2007, 15:3510.
34. Masters L.T., Pryor J.C., Nelson P.K. Angiographic findings associated with intra-axial intracranial tumors. Neuroimaging Clin N Am 1996, 6:739-749.
35. Wickbom I. Tumor circulation. Radiology of the skull and brain 1974, 2257-2285. Mosby, St Louis, USA. T.H. Newton, D.G. Potts (Eds.).
36. Osborn A.G. Neoplasm mass effects. Diagnostic cerebral angiography 1999, 313-340. Lippincott, Williams and Wilkins, Philadelphia, USA. 2nd ed. A.G. Osborn (Ed.).
37. Cemil B., Tun K., Polat O., Ozen O., Kaptanoglu E. Glioblastoma multiforme mimicking arteriovenous malformation. Turk Neurosurg 2009, 19:433-436.
38. Osborn A.G. Astrocytomas and other glial neoplasms. Diagnostic neuroradiology 2003, 555. Mosby, St louis, USA. A.G. Osborn (Ed.).
39. Cha S., Lupo J.M., Chen M.H., Lamborn K.R., McDermott M.W., Berger M.S., et al. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Am J Neuroradiol 2007, 28:1078-1084.
40. Sato K., Rorke L.B. Vascular bundles and wickerworks in childhood brain tumors. Pediatr Neurosci 1989, 15:105-110.
41. Fulham M.J., Melisi J.W., Nishimiya J., Dwyer A.J., Di Chiro G. Neuroimaging of juvenile pilocytic astrocytomas: an enigma. Radiology 1993, 189:221-225.
42. Wetzel S.G., Cha S., Law M., Johnson G., Golfinos J., Lee P., et al. Preoperative assessment of intracranial tumors with perfusion MR and a volumetric interpolated examination: a comparative study with DSA. Am J Neuroradiol 2002, 23:1767-1774.
43. Grand S.D., Kremer S., Tropres I.M., Hoffmann D.M., Chabardes S.J., Lefournier V., et al. Perfusion-sensitive MRI of pilocytic astrocytomas: initial results. Neuroradiology 2007, 49:545-550.
44. Hartmann M., Heiland S., Harting I., Tronnier V.M., Sommer C., Ludwig R., et al. Distinguishing of primary cerebral lymphoma from high-grade gliomas with perfusion-weighted magnetic resonance imaging. Neurosci Lett 2003, 338:119-122.
45. Zagzag D., Miller D.C., Kleinman G.M., Abati A., Donnenfeld H., Budzilovich G.N. Demyelinating disease versus tumor in surgical neuropathology: clues to a correct pathological diagnosis. Am J Surg Pathol 1993, 17:537-545.
46. Bing F., Kremer S., Lamalle L., Chabardes S., Ashraf A., Pasquier B., et al. Value of perfusion MRI in the study of pilocytic astrocytoma and hemangioblastoma: preliminary findings. J Neuroradiol 2009, 36(2):82-87.